Management of Non-Vitamin K Antagonist Oral Anticoagulants in the Perioperative Setting

Table 8

Essential prerequisites allowing perioperative decisions.

Molecule	Type
	Dose
	Indication
Patient	Thromboembolic risk—bleeding risk
	Renal function (CrCl—Cockroft and Gault formula)
	Hepatic function
	Concomitant drugs
	Approved NOAC’s indication
Procedure	Type and technique
	Bleeding risk
	Date of its achievement (Day 0)
Anesthesia	General and/or regional (neuroaxial or peripheral nerve blocks)